Atomni-40 (Atorvastatin 40 mg): Complete Guide

Atomni-40 is a prescription medicine marketed in India by EMK Omni Pharma, a pharmaceutical marketing company based in Mysuru, Karnataka. Each film-coated tablet contains Atorvastatin Calcium IP equivalent to Atorvastatin 40 mg, along with approved excipients. It is supplied in a pack of 10 X 10 tablets and belongs to the company's Cholesterol and Lipid Care range.

Atorvastatin 40 mg is one of the higher routine strengths of the molecule. Doctors generally consider it for people who need firmer control of LDL cholesterol than a lower strength has given, or for people whose overall cardiovascular risk is judged to be high. It is not a starter medicine that anyone should pick off a shelf.

EMK Omni Pharma markets Atomni-40. The tablets are produced for the company at GMP-certified contract manufacturing facilities and released to the market under the brand name.

Atorvastatin belongs to a group of medicines called statins, or HMG-CoA reductase inhibitors. The liver makes a large share of the cholesterol circulating in the body, and it does so using an enzyme called HMG-CoA reductase. Atorvastatin slows that enzyme down, so the liver produces less cholesterol of its own.

When the liver senses that it has less cholesterol available, it responds by pulling more LDL cholesterol out of the bloodstream through receptors on its surface. The overall effect, over weeks, is a lower LDL level in the blood, usually some reduction in triglycerides and often a small rise in HDL. Statins are also understood to have a steadying effect on the fatty deposits that build up inside artery walls, which is one reason doctors prescribe them for long periods rather than for a few days.

Keep the medicine out of the reach of children and use it only as directed by your physician.

Cholesterol care in India usually begins with a lipid profile blood test, a look at family history, blood pressure, blood sugar, weight and smoking habits. From that picture the doctor forms a view of how much cardiovascular risk a person carries.

Diet, physical activity, weight control and stopping tobacco come first and continue for life. Medicines like Atomni-40 are added when the doctor judges that lifestyle change alone will not bring the numbers to where they need to be, or when the risk is already high enough that waiting is not sensible. The tablet does not replace the lifestyle work. The two are meant to run together, with follow-up lipid tests to show whether the plan is working.

This guide continues across ten more articles, each answering a different set of questions.

Speak to your doctor before starting if you are pregnant, planning a pregnancy or breastfeeding, if you have liver disease, if you drink alcohol regularly, or if you take medicines for infection, HIV, epilepsy, heart rhythm problems or transplant care.

While you are on treatment, report unexplained muscle pain, tenderness or weakness, dark coloured urine, yellowing of the eyes or skin, persistent nausea, unusual tiredness or a rash. Also tell any new doctor or dentist that you take a statin, and keep your follow-up appointments for lipid and liver tests.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.